Company Overview of iPierian, Inc.
iPierian, Inc., a biopharmaceutical company, engages in the industrialization of induced pluripotent stem cell technology; and discovery and development of therapeutics using cells as models of human disease. It focuses on neurological diseases, including spinal muscular atrophy, amyotrophic lateral sclerosis, and Alzheimer’s disease. The company was formerly known as iZumi Bio, Inc. and changed its name in July 2009. iPierian, Inc. was founded in 2007 and is based in South San Francisco, California.
951 Gateway Boulevard
South San Francisco, CA 94080
Founded in 2007
Key Executives for iPierian, Inc.
iPierian, Inc. Key Developments
Similar Private Companies By Industry
|Venture Biodiscovery, Inc.||United States|
|Actinium Corporation||United States|
|Implicit Bioscience, Inc.||United States|
|PIC USA, Inc.||United States|
|StormBio, Inc.||United States|
Recent Private Companies Transactions
September 4, 2013
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- New York City, NY | BloombergPosted: Apr 14
- Cambridge, MA | Biogen IdecPosted: Apr 15
- Delaware | DuPontPosted: Apr 11
- San Francisco, CA | Investment Firm Providing Private and Institutional BrokeragePosted: Apr 07
Sponsored Financial Commentaries
To contact iPierian, Inc., please visit www.ipierian.com. Company data is provided by Capital IQ. Please use this form to report any data issues.